4th Circ. Skeptical Of Biotech Co.'s Tax Credit Claim
The Fourth Circuit questioned a biotechnology company's claim that it was wrongly deprived of tax credits for drug research, asking Thursday why the company rejected the U.S. Tax Court's ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article